Heart Failure 2026 is the world’s leading congress for heart failure specialists, attracting more than 5,000 clinicians, researchers, nurses, allied professionals, medtech and life sciences partners, and global medical media.
Join us at the Future Frontiers Hub at the heart of Heart Failure 2026 in Barcelona. A new dedicated space for universities, start-ups, spin-offs, and early-stage industry innovators.
Submissions are now open — showcase your innovative projects transforming heart failure diagnosis, treatment, and management.
Deadline for submission is 11 February 2026.
NEW! A unique opportunity to highlight your innovation
- Present tomorrow’s breakthroughs to an audience actively seeking new solutions in heart failure care
- Gain visibility among key decision-makers, including clinicians, researchers, and industry leaders
- Shape the future of cardiovascular medicine by positioning your innovation at the forefront of emerging practice
- Unlock collaboration and funding opportunities with potential partners, investors, and organisations
- Share your vision on a global stage at the world’s leading heart failure congress
Join us at the 'Future Frontiers in Heart Failure Hub' and help shape the future of heart failure care.
Deadline to submit is 11 February 2026.
A dedicated space to showcase your innovation: the 'Future Frontiers in Heart Failure Hub'
NEW THIS YEAR! In the exhibition area, you will benefit from a space designed to accelerate progress and give visibility to universities, start-ups, spin-offs, and early-stage industry innovators.
This dedicated hub will create a dynamic platform to connect, collaborate, and showcase solutions that can transform heart failure care.
Eligibility
This space is designed for the people and organisations driving innovation in heart failure, including Academic heart failure researchers, Clinician-innovators, Start-ups & medtech companies, Investors & industry leaders, Young clinicians, Heart failure patients...
Whether you are developing new ideas, seeking collaborations, or looking to raise visibility, the Hub is your opportunity to make an impact.
Projects must be:
- Non-commercialised products OR
- In very early development (pre-clinical, Phase 1–2, prototype) OR
- Emerging technologies with high potential in heart failure care
All submissions will be reviewed by the Heart Failure Congress Chairpersons. Successful applicants will receive a dedicated, prime space in the Exhibition at a preferential rate starting from €1,500.
Deadline to submit is 11 February 2026.
Process and Timeline
- Complete the online submission : Deadline to submit is 11 February 2026
- Initial screening: Verification of eligibility and completeness
- Scientific and strategic review : Conducted by the Congress Programme Chairs, who will independently evaluate submissions based on predefined criteria (e.g., innovation, relevance to heart failure, potential impact) 11-18 February 2026
- Final validation : Consensus review and notification of selected projects to confirm participation and invoicing/ARS procedure
- Notification of selected projects by the end of February 2026
Data Privacy
The information collected is subject to data processing and storage. The recipient of the data is the European Society of Cardiology, and ESC Staff for logistics organisation.
Your data will only be used for the organisation of the meetings in reference in this online form. Your data will be kept for a duration of 2 years.
In accordance with the chapter 3 of the European Regulation 2016/679 with regards to data protection, you have the right to request from ESC, access to and rectification or erasure of your personal data or restriction of processing concerning your data or to object to processing as well as the right to data portability.
For such, please contact dataprivacy@escardio.org (be aware that a proof of identity will be requested during the process via a secure web link).
You have the right to lodge a complaint with a supervisory authority, and for information, ESC has appointed a Data Protection Officer that you can reach at dpo@escardio.org.
We will not disclose your identity to any third party.
Our mission: To reduce the burden of cardiovascular disease.